Home » Topics » Regulatory

Regulatory
RSS

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

FDA approves Botox for upper limb spasticity in adults

March 11, 2010

FDA approves CSL Behring's Hizentra immunoglobulin therapy

March 8, 2010

FDA grants marketing approval for Shire's VPRIV for type 1 GD

March 1, 2010

FDA approves Novartis' Menveo vaccine for meningococcal disease

Feb. 22, 2010

FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients

Feb. 12, 2010

FDA approves Xiaflex for debilitating hand disease

Feb. 4, 2010

FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients

Jan. 25, 2010

Daiichi granted Japanese approval to manufacture and market Rezaltas for hypertension

Jan. 21, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...